CLINICAL_TRIALS
trial_result
· 2021-02-24
Clinical Trial Update: Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia [Phase 2]
Summary
Phase 2 clinical trial evaluating BI 425809 on cognition and functional capacity in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-24